BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29162271)

  • 21. Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.
    Fogelman DR; Wolff RA; Kopetz S; Javle M; Bradley C; Mok I; Cabanillas F; Abbruzzese JL
    Anticancer Res; 2011 Apr; 31(4):1417-20. PubMed ID: 21508395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing is everything: Brca2 and p53 mutations in pancreatic cancer.
    Morton JP; Steele CW; Sansom OJ
    Gastroenterology; 2011 Apr; 140(4):1143-6. PubMed ID: 21352873
    [No Abstract]   [Full Text] [Related]  

  • 23. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
    Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
    Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.
    Laitman Y; Keinan Boker L; Liphsitz I; Weissglas-Volkov D; Litz-Philipsborn S; Schayek H; Friedman E
    Breast Cancer Res Treat; 2015 Apr; 150(3):631-5. PubMed ID: 25788227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.
    Ozçelik H; Schmocker B; Di Nicola N; Shi XH; Langer B; Moore M; Taylor BR; Narod SA; Darlington G; Andrulis IL; Gallinger S; Redston M
    Nat Genet; 1997 May; 16(1):17-8. PubMed ID: 9140390
    [No Abstract]   [Full Text] [Related]  

  • 27. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
    Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report.
    Rose PG; Shrigley R; Wiesner GL
    Gynecol Oncol; 2000 May; 77(2):319-20. PubMed ID: 10785486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.
    Sharma MB; Carus A; Sunde L; Hamilton-Dutoit S; Ladekarl M
    Acta Oncol; 2016; 55(3):377-81. PubMed ID: 26004055
    [No Abstract]   [Full Text] [Related]  

  • 32. The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
    Martinez-Useros J; Garcia-Foncillas J
    Biomed Res Int; 2016; 2016():1869304. PubMed ID: 28078281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple primary tumors as an indicator for p16INK4a germline mutations in pancreatic cancer patients?
    Gerdes B; Bartsch DK; Ramaswamy A; Kersting M; Wild A; Schuermann M; Frey M; Rothmund M
    Pancreas; 2000 Nov; 21(4):369-75. PubMed ID: 11075991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient.
    Copur MS; Tun SM; Vargas L; Merani S; Wedel W; Duckert R; Horn A; Lintel N; Herold D; Lavudi S
    Clin Colorectal Cancer; 2023 Mar; 22(1):160-165. PubMed ID: 36404245
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
    Carcangiu ML; Peissel B; Pasini B; Spatti G; Radice P; Manoukian S
    Am J Surg Pathol; 2006 Oct; 30(10):1222-30. PubMed ID: 17001151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.
    Coakley M; Cleary V; Power N; O'Reilly S
    Eur J Hum Genet; 2017 Feb; 25(2):167-168. PubMed ID: 27759028
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.
    Peterlongo P; Catucci I; Pasquini G; Verderio P; Peissel B; Barile M; Varesco L; Riboni M; Fortuzzi S; Manoukian S; Radice P
    Breast Cancer Res Treat; 2011 Apr; 126(3):825-8. PubMed ID: 21184274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.